Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aude G Chapuis

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|December 29, 2025
Intrathecal rituximab for the treatment of Epstein-Barr virus-associated encephalitisAude G Chapuis, Johnnie J Orozco, Filippo Milano
Trends in Cancer|September 29, 2020
The Anticancer Potential of T Cell Receptor-Engineered T CellsMatyas Ecsedi, Megan S McAfee, Aude G Chapuis
Current Hematologic Malignancy Reports|April 21, 2016
T-Cell Receptor-Engineered Cells for the Treatment of Hematologic MalignanciesNasheed M Hossain, Aude G Chapuis, Roland B Walter
International Immunology|February 13, 2019
Immunotherapy for skin cancerKelly G Paulson, Miranda C Lahman, Aude G Chapuis, et al.
The Journal of Investigative Dermatology|April 17, 2021
Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell CarcinomaMiranda C Lahman, Kelly G Paulson, Paul T Nghiem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target MalignanciesThomas M Schmitt, Ingunn M Stromnes, Aude G Chapuis, et al.
Human Gene Therapy|September 11, 2023
Genome Editing in Engineered T Cells for Cancer ImmunotherapyChiara Bonini, Aude G Chapuis, Michael Hudecek, et al.
Immunological Reviews|December 17, 2013
Re-adapting T cells for cancer therapy: from mouse models to clinical trialsIngunn M Stromnes, Thomas M Schmitt, Aude G Chapuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2026
Safety and Clinical Outcomes of Pooled Donor, Nonengrafting Expanded Progenitor Cells in Single-Unit Cord Blood TransplantationFilippo Milano, Ann Dahlberg, Jenna Pedersen, et al.
Blood|October 19, 2017
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemiaShannon K Oda, Andrew W Daman, Nicolas M Garcia, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|December 29, 2025
Intrathecal rituximab for the treatment of Epstein-Barr virus-associated encephalitisAude G Chapuis, Johnnie J Orozco, Filippo Milano
Trends in Cancer|September 29, 2020
The Anticancer Potential of T Cell Receptor-Engineered T CellsMatyas Ecsedi, Megan S McAfee, Aude G Chapuis
Current Hematologic Malignancy Reports|April 21, 2016
T-Cell Receptor-Engineered Cells for the Treatment of Hematologic MalignanciesNasheed M Hossain, Aude G Chapuis, Roland B Walter
International Immunology|February 13, 2019
Immunotherapy for skin cancerKelly G Paulson, Miranda C Lahman, Aude G Chapuis, et al.
The Journal of Investigative Dermatology|April 17, 2021
Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell CarcinomaMiranda C Lahman, Kelly G Paulson, Paul T Nghiem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target MalignanciesThomas M Schmitt, Ingunn M Stromnes, Aude G Chapuis, et al.
Human Gene Therapy|September 11, 2023
Genome Editing in Engineered T Cells for Cancer ImmunotherapyChiara Bonini, Aude G Chapuis, Michael Hudecek, et al.
Immunological Reviews|December 17, 2013
Re-adapting T cells for cancer therapy: from mouse models to clinical trialsIngunn M Stromnes, Thomas M Schmitt, Aude G Chapuis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2026
Safety and Clinical Outcomes of Pooled Donor, Nonengrafting Expanded Progenitor Cells in Single-Unit Cord Blood TransplantationFilippo Milano, Ann Dahlberg, Jenna Pedersen, et al.
Blood|October 19, 2017
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemiaShannon K Oda, Andrew W Daman, Nicolas M Garcia, et al.
Pageof 5